Overview

Rallis India Ltd is a chemical manufacturer headquartered in Mumbai, India, founded in 1948, with 501-1,000 employees.

Active pharmaceutical ingredients supplied

Substances Rallis India Ltd is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Rallis India Ltd holds 0 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • CROMOLYN SODIUMInactive1989-09-15
  • NAPROXEN SODIUMInactive1988-07-13
  • IBUPROFEN U.S.P.Inactive1987-12-29
  • NAPROXENInactive1987-08-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Rallis India Ltd in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Rallis India Ltd? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.